American Journal of Medical Case Reports
ISSN (Print): 2374-2151 ISSN (Online): 2374-216X Website: http://www.sciepub.com/journal/ajmcr Editor-in-chief: Samy, I. McFarlane
Open Access
Journal Browser
Go
American Journal of Medical Case Reports. 2015, 3(3), 91-92
DOI: 10.12691/ajmcr-3-3-11
Open AccessCase Report

First-Aid Treatment of Hyperkalemia by Nebulised Salbutamol: An Experience in Pseudohypoaldosteronism

Yuichiro Imai1, Junji Takaya1, and Kazunari Kaneko1

1Department of Pediatrics, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi, Osaka 570-8506, Japan

Pub. Date: February 25, 2015

Cite this paper:
Yuichiro Imai, Junji Takaya and Kazunari Kaneko. First-Aid Treatment of Hyperkalemia by Nebulised Salbutamol: An Experience in Pseudohypoaldosteronism. American Journal of Medical Case Reports. 2015; 3(3):91-92. doi: 10.12691/ajmcr-3-3-11

Abstract

In the present case with primary pseudohypoaldosteronism, severe hypekalemia was treated with salbutamol inhalation in acute phase. Transcellular hypokalemic effect of salbutamol is related to the activation of Na-K pump on the cell membrane. Although use of salbutamol inhalation in hyperkalemia was previously described, it has not been widely used. The administration of salbutamol by inhalation is a simple, safe and reasonably effective method for treatment of hyperkalemia even in children.

Keywords:
hyperkalemia pseudohypoaldosteronism treatment

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

Figure of 1

References:

[1]  Hanukoglu A, “Type 1 pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects,” J Clin Endocrinol Metab, 70:936-944. 1991.
 
[2]  Geller DS, Zhang J, Zennaro MC, Vallo-Boado A, Rodriguez-Soriano J, Furu L, Haws R, Metzger D, Bothlho B, Karaviti L, Haqq AM, Corey H, Janssens S, Carvol P, Lifton RP, “Autosomal dominant pseudohypoaldosteronism type 1: mechanisms, evidence for neonatal lethality, and phenotypic expression in adults,” J Am Soc Nephrol, 17:1429-1436. 2006.
 
[3]  Batlle DC, Arruda JA, Kurtzman NA, “Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy,” N Engl J Med, 304:373-380. 1981.
 
[4]  McClure RJ, Prasad VK, Brocklebank JT, “Treatment of hyperkalemia using intravenous and nebulised salbutamol,” Arch Dis Child, 70:126-128. 1994.
 
[5]  Mahoney BA, Smith WA, Lo DS, Tsoi K, Tonelli M, Clase CM, “Emergency interventions for hyperkalaemia,” Cochrane Database Syst Rev 2005 Apr 18;(2):CD003235.